India, Oct. 6 -- Glenmark Therapeutics Inc., USA, has launched Adapalene Gel USP, 0.1% (OTC) in new pump-pack packaging, expanding its dermatology product offerings in the US.
The product contains the same active ingredient as Differin® Gel 0.1%, an over-the-counter acne treatment. The new pump format is designed to provide consumers with a more convenient and user-friendly dispensing option.
According to Nielsen syndicated data for the 52-week period ended September 5, 2026, the US market for Differin® Gel 0.1% generated approximately $45.8 million in annual sales.
Glenmark said the launch strengthens its growing US dermatology portfolio while supporting its focus on providing high-quality and affordable healthcare products.
Pu...